Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors.
about
Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@ast
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@en
type
label
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@ast
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@en
prefLabel
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@ast
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@en
P2093
P2860
P1433
P1476
Immune-Related Adverse Events ...... ammed Cell Death 1 Inhibitors.
@en
P2093
Chethan Ramamurthy
Daniel M Geynisman
Elizabeth Handorf
Elizabeth R Plimack
Hossein Borghaei
Jamie Doyle
Jessica Bauman
John O'Neill
Julia Judd
Matthew Zibelman
P2860
P356
10.1634/THEONCOLOGIST.2017-0133
P577
2017-06-26T00:00:00Z